Listing contains 128 trial(s)
Head & Neck, Laryngeal Cancer
Lab
Direct Measurement of Rates of Synthesis and Turnover of T Lymphocytes in Head and Neck Cancer (HNC) Subjects and Healthy Controls. Study Number: 02-034 |
Phase I
Preliminary Assessment of the Safety and Biological Activity of Intratumoral STAT3 Decoy in Surgically Resectable Head and Neck Squamous Cell Carcinoma Study Number: 07-022 |
Phase II
Phase II Trial of Cetuximab and Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer Study Number: 05-087 |
Re-Irradiation with Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck Study Number: 06-093 |
A Phase II Trial of Postoperative Radiation, Cisplatin and Pantiumumab in Locally Advanced Head and Neck Cancer Study Number: 06-120 |
Phase II Trial of Doxorubicin and Bortezomib in Patients with Incurable Adenoid Cystic Carcinoma of the Head and Neck Study Number: 06-124 |
Randomized Phase II Trial of Radiation, Cetuximab (C225) and Pemetrexed With or Without Bevacizumab in patients with locally advanced Head and Neck Cancer Study Number: 07-021 |
A Randomized Phase II Open-Label Study of IMC-A12 , as a Single Agent or in Combination with Cetuximab, in Patients with Recurrent or Metastatic SCCHN and Disease Progression on Prior Platinum-Based Chemotherapy Study Number: 07-146 |
Phase III
A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer Study Number: 08-119 |
Pilot
Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC Family Kinases Using Erlotinib and Dasatinib in Aerodigestive Tract Cancers Study Number: 07-124 |
Tissue and/or blood banking study
The University of Pittsburgh Tissue Bank for Head and Neck Cancer Study Number: 99-069 |
